Current and emerging targets to treat neuropathic pain

J Med Chem. 2007 May 31;50(11):2543-6. doi: 10.1021/jm061015w. Epub 2007 May 10.
No abstract available

MeSH terms

  • Animals
  • Calcium Channels / drug effects
  • Calcium Channels / physiology
  • Humans
  • Ion Channel Gating / drug effects
  • KCNQ Potassium Channels / drug effects
  • Pain / drug therapy*
  • Pain / metabolism
  • Pain / physiopathology
  • Peripheral Nervous System Diseases / drug therapy*
  • Peripheral Nervous System Diseases / metabolism
  • Peripheral Nervous System Diseases / physiopathology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channel Blockers / therapeutic use
  • Receptors, Metabotropic Glutamate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Sodium Channel Blockers / pharmacology
  • Sodium Channel Blockers / therapeutic use
  • TRPV Cation Channels / drug effects

Substances

  • Calcium Channels
  • KCNQ Potassium Channels
  • Potassium Channel Blockers
  • Receptors, Metabotropic Glutamate
  • Receptors, N-Methyl-D-Aspartate
  • Sodium Channel Blockers
  • TRPV Cation Channels
  • TRPV1 receptor
  • metabotropic glutamate receptor type 1
  • voltage gated calcium channel subunit Ca alpha2delta-1, human